| Kathryn A Craig, MD | |
|
12935 Gregory St, Blue Island, IL 60406-2428 | |
| (708) 587-2000 | |
| (630) 941-4333 |
| Full Name | Kathryn A Craig |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 29 Years |
| Location | 12935 Gregory St, Blue Island, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235122854 | NPI | - | NPPES |
| 036-098353 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036-098353 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Proctor Hospital | Peoria, IL | Hospital |
| Warner Hospital And Health Services | Clinton, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Of Clinton | 0042203127 | 13 |
| Epss Peoria Llc | 1850587007 | 21 |
| Epss Llc - East Series | 8729213459 | 7 |
News Archive
In a unique communications partnership, the Royal Society of Medicine and ITN Productions have launched a news and current affairs-style programme.
A new material that fuses biological and synthetic substances at the molecular level speeds bone and cartilage repair. Its creators at the Technion-Israel Institute of Technology say laboratory studies have shown the new gel promotes healing by gluing bone pieces together and stimulating tissue development.
Kronos Incorporated today announced that it has entered into a definitive agreement to acquire API Healthcare Corporation from Francisco Partners. Closing of the transaction is subject to regulatory approval and customary closing conditions.
Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).
Timely administration of anti-Parkinson drugs is a significant issue for hospitalized patients with Parkinson's disease (PD) with late or missed doses resulting in longer stays and worse outcomes.
› Verified 7 days ago
| Entity Name | Pekin Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245355411 PECOS PAC ID: 4789676438 Enrollment ID: O20040401000798 |
News Archive
In a unique communications partnership, the Royal Society of Medicine and ITN Productions have launched a news and current affairs-style programme.
A new material that fuses biological and synthetic substances at the molecular level speeds bone and cartilage repair. Its creators at the Technion-Israel Institute of Technology say laboratory studies have shown the new gel promotes healing by gluing bone pieces together and stimulating tissue development.
Kronos Incorporated today announced that it has entered into a definitive agreement to acquire API Healthcare Corporation from Francisco Partners. Closing of the transaction is subject to regulatory approval and customary closing conditions.
Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).
Timely administration of anti-Parkinson drugs is a significant issue for hospitalized patients with Parkinson's disease (PD) with late or missed doses resulting in longer stays and worse outcomes.
› Verified 7 days ago
| Entity Name | City Of Clinton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275695470 PECOS PAC ID: 0042203127 Enrollment ID: O20040405001569 |
News Archive
In a unique communications partnership, the Royal Society of Medicine and ITN Productions have launched a news and current affairs-style programme.
A new material that fuses biological and synthetic substances at the molecular level speeds bone and cartilage repair. Its creators at the Technion-Israel Institute of Technology say laboratory studies have shown the new gel promotes healing by gluing bone pieces together and stimulating tissue development.
Kronos Incorporated today announced that it has entered into a definitive agreement to acquire API Healthcare Corporation from Francisco Partners. Closing of the transaction is subject to regulatory approval and customary closing conditions.
Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).
Timely administration of anti-Parkinson drugs is a significant issue for hospitalized patients with Parkinson's disease (PD) with late or missed doses resulting in longer stays and worse outcomes.
› Verified 7 days ago
| Entity Name | Epss Peoria Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831421056 PECOS PAC ID: 1850587007 Enrollment ID: O20101130000569 |
News Archive
In a unique communications partnership, the Royal Society of Medicine and ITN Productions have launched a news and current affairs-style programme.
A new material that fuses biological and synthetic substances at the molecular level speeds bone and cartilage repair. Its creators at the Technion-Israel Institute of Technology say laboratory studies have shown the new gel promotes healing by gluing bone pieces together and stimulating tissue development.
Kronos Incorporated today announced that it has entered into a definitive agreement to acquire API Healthcare Corporation from Francisco Partners. Closing of the transaction is subject to regulatory approval and customary closing conditions.
Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).
Timely administration of anti-Parkinson drugs is a significant issue for hospitalized patients with Parkinson's disease (PD) with late or missed doses resulting in longer stays and worse outcomes.
› Verified 7 days ago
| Entity Name | Epss Llc - East Series |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841533882 PECOS PAC ID: 8729213459 Enrollment ID: O20140213001518 |
News Archive
In a unique communications partnership, the Royal Society of Medicine and ITN Productions have launched a news and current affairs-style programme.
A new material that fuses biological and synthetic substances at the molecular level speeds bone and cartilage repair. Its creators at the Technion-Israel Institute of Technology say laboratory studies have shown the new gel promotes healing by gluing bone pieces together and stimulating tissue development.
Kronos Incorporated today announced that it has entered into a definitive agreement to acquire API Healthcare Corporation from Francisco Partners. Closing of the transaction is subject to regulatory approval and customary closing conditions.
Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).
Timely administration of anti-Parkinson drugs is a significant issue for hospitalized patients with Parkinson's disease (PD) with late or missed doses resulting in longer stays and worse outcomes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn A Craig, MD 12935 Gregory St, Blue Island, IL 60406-2428 Ph: (708) 587-2000 | Kathryn A Craig, MD 12935 Gregory St, Blue Island, IL 60406-2428 Ph: (708) 587-2000 |
News Archive
In a unique communications partnership, the Royal Society of Medicine and ITN Productions have launched a news and current affairs-style programme.
A new material that fuses biological and synthetic substances at the molecular level speeds bone and cartilage repair. Its creators at the Technion-Israel Institute of Technology say laboratory studies have shown the new gel promotes healing by gluing bone pieces together and stimulating tissue development.
Kronos Incorporated today announced that it has entered into a definitive agreement to acquire API Healthcare Corporation from Francisco Partners. Closing of the transaction is subject to regulatory approval and customary closing conditions.
Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).
Timely administration of anti-Parkinson drugs is a significant issue for hospitalized patients with Parkinson's disease (PD) with late or missed doses resulting in longer stays and worse outcomes.
› Verified 7 days ago
Dr. Jeffrey Bzdusek, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 12935 Gregory St, Blue Island, IL 60406 Phone: 708-597-2000 Fax: 708-824-4494 | |
Daniel R Kowalzyk, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12935 S. Gregory St., Blue Island, IL 60406 Phone: 708-597-2000 Fax: 708-824-4494 | |
Darryl J. Fleishman, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12935 Gregory St, Blue Island, IL 60406 Phone: 708-597-2000 | |
Anthony Kelly Goldboss, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12935 Gregory St, Blue Island, IL 60406 Phone: 708-597-2000 Fax: 708-824-4516 | |
Dr. Faheem M Jesani, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12935 Gregory St, Blue Island, IL 60406 Phone: 708-597-2000 | |
Dr. Whitney Michelle Dawson, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12935 Gregory St, Blue Island, IL 60406 Phone: 708-597-2000 |